Agentic AI promises true operational transformation yet 90% of models reportedly fail to reach full deployment. The gap between promise and production reality remains wide. What does it actually take to scale autonomous AI safely and reliably in GMP environments?

Continuous manufacturing, process intensification, digitalisation and AI-driven analytics promise to compress pharma timelines. But they remain the exception, not the norm. This panel takes stock of what is actually working and where the biggest remaining bottlenecks lie.

Pharma manufacturing generates vast process, quality and supply chain data yet most remains siloed. Pre-competitive data sharing is beginning to unlock collective intelligence and strengthen supply resilience. But what are the practical, regulatory and cultural barriers, and what does genuine data collaboration look like in practice?

Sustainability continues to move from regulatory checkbox to a source of genuine innovation and commercial differentiation. This session spotlights practical green chemistry approaches being deployed across pharma manufacturing and how they can become embedded in standard practice.

New modalities, autonomous systems, greener chemistry and more resilient supply chains are reshaping pharmaceutical manufacturing. This closing conversation asks: what does the industry of the future actually look like, and how far away is it? Panellists will examine which technologies are nearing tipping point, where the industry is still telling itself comfortable stories, and what leaders must do now to be ready.